Needham & Company LLC Issues Positive Forecast for Equifax (NYSE:EFX) Stock Price

Equifax (NYSE:EFX – Get Free Report) had its price target lifted by equities research analysts at Needham & Company LLC from $210.00 to $220.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the credit services provider’s stock. Needham & Company LLC‘s target price indicates a potential upside of 16.82% from the stock’s current price.

A number of other brokerages also recently commented on EFX. Stifel Nicolaus reduced their price objective on Equifax from $235.00 to $217.00 and set a “buy” rating on the stock in a research report on Wednesday, October 21st. Royal Bank Of Canada lowered shares of Equifax from an “outperform” rating to a “sector perform” rating and upped their price objective for the stock from $177.00 to $189.00 in a report on Monday, October 26th. The Goldman Sachs Group restated a “neutral” rating on shares of Equifax in a report on Tuesday, October 20th. BMO Capital Markets lifted their target price on Equifax from $160.00 to $175.00 and gave the company a “market perform” rating in a research report on Wednesday, October 21st. Finally, Credit Suisse Group set a $160.00 price target on shares of Equifax in a research note on Wednesday, September 30th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $201.00.

Check Out Our Latest Research Report on Equifax

Equifax Price Performance

Shares of NYSE EFX opened at $188.33 on Monday. The firm has a 50-day simple moving average of $166.23 and a 200-day simple moving average of $176.20. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $22.04 billion, a price-to-earnings ratio of 30.42, a price-to-earnings-growth ratio of 1.93 and a beta of 1.27. Equifax has a 52 week low of $137.01 and a 52 week high of $228.67.

Equifax (NYSE:EFX – Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The credit services provider reported $2.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $0.06. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.69 billion. Equifax had a net margin of 11.27% and a return on equity of 22.48%. Equifax’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.04 earnings per share. On average, equities analysts predict that Equifax will post 8.50 earnings per share for the current fiscal year.

Insider Transactions at Equifax

In other news, EVP Jamil Farshchi sold 15,110 shares of the stock in a transaction on Monday, November 9th. The stock was sold at an average price of $189.77, for a total value of $2,867,424.70. Following the sale, the executive vice president directly owned 39,290 shares in the company, valued at approximately $7,456,063.30. This trade represents a 27.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Begor sold 37,792 shares of Equifax stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $182.80, for a total value of $6,908,377.60. Following the completion of the transaction, the chief executive officer owned 289,922 shares of the company’s stock, valued at approximately $52,997,741.60. This trade represents a 11.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 61,402 shares of company stock valued at $11,332,342. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Equifax

A number of hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in shares of Equifax during the second quarter worth approximately $1,491,357,000. Soroban Capital Partners LP raised its holdings in Equifax by 310.5% in the first quarter. Soroban Capital Partners LP now owns 4,184,569 shares of the credit services provider’s stock valued at $753,515,000 after acquiring an additional 3,165,120 shares in the last quarter. Generation Investment Management LLP acquired a new stake in Equifax in the second quarter valued at approximately $290,868,000. Bank of America Corp DE purchased a new position in Equifax in the second quarter worth approximately $187,215,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Equifax in the second quarter worth approximately $174,843,000. Institutional investors and hedge funds own 96.20% of the company’s stock.

About Equifax

(Get Free Report)

Equifax Inc. is a global data, analytics and technology company best known as one of the major consumer credit reporting agencies in the United States. The company traces its history to 1899, when it was founded as the Retail Credit Company, and adopted the Equifax name in 1975. Equifax provides consumer and business credit information, credit reports and scores, and tools for identity verification and fraud prevention. Its products also help businesses assess risk and make decisions about lending, customer relationships and marketing.

Read More

Analyst Recommendations for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.